Measuring aniseikonia and investigating neuroplasticity and image factors in amblyopia (MAGNIFY): study protocol for a randomised clinical trial.

Jayshree SouthTina GaoMelinda CalderwoodJason TuruwhenuaPaul RobertsArier LeeAndrew CollinsJoanna Black

Published in: Trials (2022)

Australian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620000061932 . Registered on 24 January 2020. Protocol 15th November 2019, version one.

Keyphrases

clinical trial
open label
phase ii
double blind
deep learning
randomized controlled trial
psychometric properties
study protocol
phase iii
placebo controlled
machine learning